Investing.com cites MXN 71.28 fair value for Medica Sur stock

Published on 10/16/2026 at 02:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Medica Sur posted MXN 1.14 billion revenue and MXN 1.10 EPS for June 2026. December 2, 2026 is the next reported results date for Medica Sur stock.

Valuation and reporting milestones

A valuation model put Medica Sur at MXN 71.28 on October 6, 2026.
June 2026 revenue was MXN 1.14 billion and earnings per share were MXN 1.10.
The company had a MXN 5.7 billion market capitalization as of October 15, 2026.
The next reported results date is December 2, 2026.

Medica Sur, MXP606391060, Illustration mit AI erstellt.

Medica Sur (MXP606391060) was assigned a MXN 71.28 fair value in an October 6, 2026 report from Investing.com. The latest quoted BMV price was MXN 52.50 on October 15, 2026, giving the valuation discussion a concrete market reference.

Valuation moves above the market

The October 6 report said the fair value had risen to MXN 71.28 after Médica Sur's fundamentals improved. It cited earnings of MXN 271.08 million and EBITDA of MXN 53.26 million, but did not identify a reporting period for those figures, so the June quarter provides the cleaner current operating reference.

Against the MXN 52.50 BMV price on October 15, 2026, the MXN 71.28 fair value stands 35.77 percent above the quoted level. That gap describes a model output rather than a guaranteed return, and the report also noted that the valuation depended on discounted cash flow, comparable-company and dividend models.

Three recent reporting milestones

Chronology: on December 3, 2025, Médica Sur reported MXN 1.18 billion in revenue for the September 2025 period; on June 3, 2026, it reported MXN 1.20 billion for the March 2026 period; and on October 6, 2026, the fair value reached MXN 71.28, according to Investing.com and Investing.com.

What does the June quarter show?

The June 2026 quarter produced MXN 1.14 billion in revenue and MXN 1.10 in earnings per share, based on Investing.com. Revenue was 5.00 percent below the MXN 1.20 billion reported for March 2026, while earnings per share were 8.33 percent lower than MXN 1.20. The sequential comparison gives investors a more measured counterweight to the fair value signal.

Next reporting date

The next reported results date is December 2, 2026, according to Investing.com. The BMV's issuer page identifies Medica Sur as an active B-series issuer under ticker MEDICA and lists the second-quarter 2026 financial filing dated July 31, 2026, according to BMV.

Market value and trading context

Medica Sur had a MXN 5.7 billion market capitalization on October 15, 2026. Its quoted 52-week range was MXN 48.50 to MXN 62.50 on that date, placing the latest MXN 52.50 price above the low and below the high.